Preeclampsia does not share common risk alleles in 9p21 with coronary artery disease and type 2 diabetes
Tea Kaartokallio, A Inkeri Lokki, Hanna Peterson, Katja Kivinen, Leena Hiltunen, Elina Salmela, Tuuli Lappalainen, Paula Maanselka, Sanna Heino, Sakari Knuutila, Ayat Sayed, Lucilla Poston, Shaun P Brennecke, Matthew P Johnson, Linda Morgan, Eric K Moses, Juha Kere, Hannele Laivuori
Annals of Medicine | TAYLOR & FRANCIS LTD | Published : 2016
Awarded by Australian National Health and Medical Research Council
Awarded by National Institutes of Health of the USA
This study was supported by Academy of Finland; Finnish Medical Foundation, Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation, Paivikki and Sakari Sohlberg Foundation; Research Funds of the University of Helsinki; Government Special state subsidy for Health Sciences (EVO funding) at Helsinki and Uusimaa Hospital District.Tea Kaartokallio was supported by Doctoral Programme in Biomedicine (DPBM), Doctoral Programme in Clinical Research (KLTO), Research Foundation of the University of Helsinki and Biomedicum Helsinki Foundation.Ayat Sayed was supported by a grant from the Egyptian Ministry of Higher Education.Elina Salmela was supported by Antti and Jenny Wihuri Foundation.Tuuli Lappalainen was supported by Emil Aaltonen Foundation.The Australian and New Zealand component of the study were funded by grants from the Australian National Health and Medical Research Council (# 1053152) and the National Institutes of Health of the USA (# HD049847). Funding for the UK VIP (vitamins in pre-eclampsia) trial was provided by the Wellcome Trust.